Plunkett Research Online: Advaxis Inc

ADVAXIS INC (ADXS:NAS) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Advaxis Inc. is a biotechnology company utilizing multiple mechanisms of immunity with the intent to develop cancer vaccines that are more effective and safer than existing vaccines. The Company believes that by using its licensed Listeria System to engineer a live attenuated Listeria monocytogenes.....



Advaxis Inc
Ticker: ADXS
Exchange: NAS
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 609 452-9813
Fax:
Address: 305 College Road East
Princeton, NJ 8540 United States

Types Of Business
Industry Ranks

Industry NAICS code:

Pharmaceuticals
Cancer Vaccines
ContactsDescription

Molly HendersonCFO/Chief Accounting Officer/Executive VP
Andres GutierrezChief Medical Officer/Executive VP
See More
Advaxis Inc. is a biotechnology company utilizing multiple mechanisms of immunity with the intent to develop cancer vaccines that are more effective and safer than existing vaccines. The Company believes that by using its licensed Listeria System to engineer a live attenuated Listeria monocytogenes.....See More See More

Auditor: Marcum LLP
Legal Advisor:
$USD, In whole numbers,
except marked * or %
201920182017201620152014
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and AffiliatesTop Salaries
NameTitleSalary (US$)Bonus (US$)
Other ThoughtsCorporate Culture

Apparent Female Officers or Directors: